{
  "id": 998098,
  "name": "Defined daily doses per 1000 inhabitants per day of  orally administered  Antibacterials (ATC J01, A07AA, P01AB) - imidazole derivatives (j01xd) used",
  "unit": "defined daily doses per 1000 inhabitants per day",
  "createdAt": "2024-11-19T12:34:30.000Z",
  "updatedAt": "2025-10-23T19:42:08.000Z",
  "coverage": "",
  "timespan": "2018-2022",
  "datasetId": 6808,
  "columnOrder": 0,
  "shortName": "did__antimicrobialclass_antibacterials__atc_j01__a07aa__p01ab__atc4name_imidazole_derivatives__j01xd__routeofadministration_o",
  "catalogPath": "grapher/antibiotics/2024-11-12/antimicrobial_usage/class#did__antimicrobialclass_antibacterials__atc_j01__a07aa__p01ab__atc4name_imidazole_derivatives__j01xd__routeofadministration_o",
  "dimensions": {
    "years": {
      "values": [
        {
          "id": 2018
        },
        {
          "id": 2020
        },
        {
          "id": 2022
        },
        {
          "id": 2021
        }
      ]
    },
    "entities": {
      "values": [
        {
          "id": 11,
          "name": "Poland",
          "code": "POL"
        },
        {
          "id": 127,
          "name": "South Korea",
          "code": "KOR"
        },
        {
          "id": 92,
          "name": "Romania",
          "code": "ROU"
        }
      ]
    }
  },
  "descriptionShort": "Total [defined daily doses](#dod:defined-daily-doses) of antimicrobials used per 1000 inhabitants per day.",
  "type": "float",
  "dataChecksum": "6319620526664272097",
  "metadataChecksum": "-3776759178855963644",
  "datasetName": "WHO GLASS",
  "updatePeriodDays": 365,
  "datasetVersion": "2024-11-12",
  "nonRedistributable": false,
  "display": {
    "unit": "defined daily doses per 1000 inhabitants per day",
    "numDecimalPlaces": 1
  },
  "schemaVersion": 2,
  "presentation": {
    "topicTagsLinks": [
      "Global Health"
    ]
  },
  "origins": [
    {
      "id": 2033,
      "titleSnapshot": "WHO GLASS - Global Antimicrobial Use data",
      "title": "WHO GLASS",
      "description": "Inappropriate use of antimicrobials in humans is a primary driver of antimicrobial resistance (AMR) emergence and spread. In 2020, WHO launched GLASS antimicrobial use (GLASS AMU), previously called GLASS AMC, to monitor the quantity and types of antimicrobial s us ed at the national and global levels. WHO invites Countries, Areas, and Territories (CTAs) to enrol in GLASS AMU and commit to building or strengthening their national AMU surveillance system and, when ready, to reporting their national AMU data. Data calls are opened every year.",
      "producer": "WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS)",
      "citationFull": "Antimicrobial Resistance and Use Surveillance System (GLASS) 2024: Antimicrobial Use data contextual information and antimicrobial use estimates by ATC4 subgroup and AWaRe, 2016-2022. Geneva, World Health Organization; 2024.",
      "attributionShort": "WHO GLASS",
      "urlMain": "https://worldhealthorg.shinyapps.io/glass-dashboard/_w_053a572c/#!/amu",
      "urlDownload": "https://worldhealthorg.shinyapps.io/glass-dashboard/_w_053a572c/data/global/GLASS-AMU_2016-2022_dataset.xlsx",
      "dateAccessed": "2024-11-12",
      "datePublished": "2024-09-16",
      "license": {
        "url": "https://www.who.int/about/policies/terms-of-use",
        "name": "Â© 2024 WHO"
      }
    }
  ]
}